4-hydroxytetrahydropyran-2-ones and the corresponding dihydroxycarboxylic acid derivatives, salts and esters, process for their preparation, their use as pharmaceuticals, and pharmaceutical preparations and precursors
CA 2024849 C · Owner: KEßELER, KURT · Inventors: KEßELER, KURT; Beck, Gerhard; Jendralla, Heiner
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
1-, 4-Hydroxytetrahydropyran-2-ones and the corresponding dihydroxycarboxylic acid derivatives, salts and esters process for their preparation, their use as pharmaceuticals, and pharmaceutical preparations and precursors compounds of the formula I, and the corresponding open-chain dihydroxycarboxylic acids of the formula II, in which X, Y R1, R2, R3, R4 and R5 have the meanings indicated, and also their pharmacologically tolerable salts with bases and their pharmacologically tolerable esters, processes for the preparation of these compounds their use as pharmaceuticals and pharmaceutical preparations are described. In addition, compounds of the formula III, -2-, in which R1, R2, R3, R4 R5, …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 7, 1990 and granted January 1, 2002. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended September 7, 2010.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 7, 2012.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.